
Raya Therapeutic Announces Two Posters at the ENCALS Meeting in Turin, Italy June 3-6
Kim Staats, PhD., to present results of preclinical studies with RT1978 (Epertinib) and the combination of 2 NCEs with distinct mechanisms (RT1972 & RT1999). MONTREAL, QUEBEC, CANADA, June 3, 2025 /EINPresswire.com/ -- Raya Therapeutic Inc. (“Raya …